Interrogating the variable loadings of PCA identified attributes, such as late TA, CDX2 up, WNT-repressed, CRC stem down, and gastrointestinal pathways as the major variable pathways expressed in the MMAS-1 patients (Fig. 5F, Additional file 1: Figure S5C). This evidence concerns the gene CDX2 and colorectal carcinoma.